Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Engineering stem cells for cancer immunotherapy
Yan-Ruide Li, Yang Zhou, Adam Kramer, et al.
Trends in cancer (2021) Vol. 7, Iss. 12, pp. 1059-1073
Closed Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies
Yan-Ruide Li, Ying Fang, Zibai Lyu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 57
Exosomes: A potential tool for immunotherapy of ovarian cancer
Xiangjin Gong, Hao Chi, Dorothee Franziska Strohmer, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 47
Advancing cell-based cancer immunotherapy through stem cell engineering
Yan-Ruide Li, Zachary Spencer Dunn, Yanqi Yu, et al.
Cell stem cell (2023) Vol. 30, Iss. 5, pp. 592-610
Open Access | Times Cited: 41
CAR-NKT cell therapy: a new promising paradigm of cancer immunotherapy
Kaveh Hadiloo, Safa Tahmasebi, Abdolreza Esmaeilzadeh
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 41
Programmable synthetic receptors: the next-generation of cell and gene therapies
Fei Teng, Tongtong Cui, Li Zhou, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 19
Generation of allogeneic CAR-NKT cells from hematopoietic stem and progenitor cells using a clinically guided culture method
Yan-Ruide Li, Yang Zhou, Jiaji Yu, et al.
Nature Biotechnology (2024)
Open Access | Times Cited: 17
Engineering allorejection-resistant CAR-NKT cells from hematopoietic stem cells for off-the-shelf cancer immunotherapy
Yan-Ruide Li, Yang Zhou, Jiaji Yu, et al.
Molecular Therapy (2024) Vol. 32, Iss. 6, pp. 1849-1874
Open Access | Times Cited: 14
Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies
Yan-Ruide Li, Ying Fang, Shaoqiang Niu, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy
Yan-Ruide Li, Yang Zhou, Kwang Gi Kim, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 11, pp. 100449-100449
Open Access | Times Cited: 69
Targeting Immunosuppressive Tumor-Associated Macrophages Using Innate T Cells for Enhanced Antitumor Reactivity
Yan-Ruide Li, James Brown, Yanqi Yu, et al.
Cancers (2022) Vol. 14, Iss. 11, pp. 2749-2749
Open Access | Times Cited: 44
Mucosal-associated invariant T cells for cancer immunotherapy
Yan-Ruide Li, Kuangyi Zhou, Matthew Wilson, et al.
Molecular Therapy (2022) Vol. 31, Iss. 3, pp. 631-646
Open Access | Times Cited: 41
Engineering Induced Pluripotent Stem Cells for Cancer Immunotherapy
Yang Zhou, Miao Li, Kuangyi Zhou, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2266-2266
Open Access | Times Cited: 40
New cell sources for CAR-based immunotherapy
Marzieh Mazinani, Fatemeh Rahbarizadeh
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 24
iPSC Technology Revolutionizes CAR-T Cell Therapy for Cancer Treatment
Jiepu Zong, Yan-Ruide Li
Bioengineering (2025) Vol. 12, Iss. 1, pp. 60-60
Open Access
Generating allogeneic CAR-NKT cells for off-the-shelf cancer immunotherapy with genetically engineered HSP cells and feeder-free differentiation culture
Yan-Ruide Li, Kuangyi Zhou, Derek Lee, et al.
Nature Protocols (2025)
Closed Access
Target tumor microenvironment by innate T cells
Yan-Ruide Li, Matthew Wilson, Lili Yang
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 23
Emerging Trends in Nano-Driven Immunotherapy for Treatment of Cancer
Gayathri Kandasamy, Yugeshwaran Karuppasamy, Uma Maheswari Krishnan
Vaccines (2023) Vol. 11, Iss. 2, pp. 458-458
Open Access | Times Cited: 14
An Ex Vivo 3D Tumor Microenvironment-Mimicry Culture to Study TAM Modulation of Cancer Immunotherapy
Yan-Ruide Li, Yanqi Yu, Adam Kramer, et al.
Cells (2022) Vol. 11, Iss. 9, pp. 1583-1583
Open Access | Times Cited: 18
Graft-versus-Host Disease Modulation by Innate T Cells
Ying Fang, Yichen Zhu, Adam Kramer, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4084-4084
Open Access | Times Cited: 9
Development of Stem Cell-Derived Immune Cells for Off-the-Shelf Cancer Immunotherapies
Yan-Ruide Li, Zachary Spencer Dunn, Yang Zhou, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3497-3497
Open Access | Times Cited: 21
Genetic engineering strategies to enhance antitumor reactivity and reduce alloreactivity for allogeneic cell-based cancer therapy
Yuning Chen, Yichen Zhu, Adam Kramer, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 7
Advancements in CRISPR screens for the development of cancer immunotherapy strategies
Yan-Ruide Li, Zibai Lyu, Yanxin Tian, et al.
Molecular Therapy — Oncolytics (2023) Vol. 31, pp. 100733-100733
Open Access | Times Cited: 7
Tumor-tropic Trojan horses: Using mesenchymal stem cells as cellular nanotheranostics
A. Roşu, Behnaz Ghaemi, Jeff W. M. Bulte, et al.
Theranostics (2023) Vol. 14, Iss. 2, pp. 571-592
Open Access | Times Cited: 7
Tumor-Localized Administration of α-GalCer to Recruit Invariant Natural Killer T Cells and Enhance Their Antitumor Activity against Solid Tumors
Yan-Ruide Li, Yang Zhou, Matthew Wilson, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7547-7547
Open Access | Times Cited: 11
Engineered stem cells by emerging biomedical stratagems
Jinglin Wang, Xiaoxuan Zhang, Hanxu Chen, et al.
Science Bulletin (2023) Vol. 69, Iss. 2, pp. 248-279
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top